Cardiovascular Division, University of Virginia Health System, Charlottesville, VA 22908-0146, USA.
Am J Physiol Cell Physiol. 2011 Dec;301(6):C1470-8. doi: 10.1152/ajpcell.00149.2011. Epub 2011 Aug 24.
"Stimulated actin polymerization" has been proposed to be involved in force augmentation, in which prior submaximal activation of vascular smooth muscle increases the force of a subsequent maximal contraction by ∼15%. In this study, we altered stimulated actin polymerization by adjusting tissue length and then measured the effect on force augmentation. At optimal tissue length (1.0 L(o)), force augmentation was observed and was associated with increased prior stimulated actin polymerization, as evidenced by increased prior Y118 paxillin phosphorylation without changes in prior S3 cofilin or cross-bridge phosphorylation. Tissue length, per se, regulated Y118 paxillin, but not S3 cofilin, phosphorylation. At short tissue length (0.6 L(o)), force augmentation was observed and was associated with increased prior stimulated actin polymerization, as evidenced by reduced prior S3 cofilin phosphorylation without changes in Y118 paxillin or cross-bridge phosphorylation. At long tissue length (1.4 L(o)), force augmentation was not observed, and there were no prior changes in Y118 paxillin, S3 cofilin, or cross-bridge phosphorylation. There were no significant differences in the cross-bridge phosphorylation transients before and after the force augmentation protocol at all three lengths tested. Tissues contracted faster at longer tissue lengths; contractile rate correlated with prior Y118 paxillin phosphorylation. Total stress, per se, predicted Y118 paxillin phosphorylation. These data suggest that force augmentation is regulated by stimulated actin polymerization and that stimulated actin polymerization is regulated by total arterial stress. We suggest that K(+) depolarization first leads to cross-bridge phosphorylation and contraction, and the contraction-induced increase in mechanical strain increases Y118 paxillin phosphorylation, leading to stimulated actin polymerization, which further increases force, i.e., force augmentation and, possibly, latch.
“刺激肌动蛋白聚合”被认为参与力增强,其中血管平滑肌的先前亚最大激活增加随后最大收缩的力约 15%。在这项研究中,我们通过调整组织长度来改变刺激肌动蛋白聚合,然后测量对力增强的影响。在最佳组织长度(1.0L(o))下,观察到力增强,并且与先前刺激肌动蛋白聚合增加有关,这表现为先前 Y118 桩蛋白磷酸化增加而 S3 丝切蛋白无变化或交联桥磷酸化无变化。组织长度本身调节 Y118 桩蛋白,但不调节 S3 丝切蛋白磷酸化。在短组织长度(0.6L(o))下,观察到力增强,并且与先前刺激肌动蛋白聚合增加有关,这表现为先前 S3 丝切蛋白磷酸化减少而 Y118 桩蛋白或交联桥磷酸化无变化。在长组织长度(1.4L(o))下,观察不到力增强,并且 Y118 桩蛋白、S3 丝切蛋白或交联桥磷酸化无先前变化。在所测试的所有三个长度下,力增强方案前后的交联桥磷酸化瞬态没有显著差异。组织在较长的组织长度下收缩得更快;收缩速度与先前的 Y118 桩蛋白磷酸化相关。总应力本身预测 Y118 桩蛋白磷酸化。这些数据表明力增强受刺激肌动蛋白聚合调节,而刺激肌动蛋白聚合受总动脉应力调节。我们认为,K(+)去极化首先导致交联桥磷酸化和收缩,并且收缩引起的机械应变增加增加 Y118 桩蛋白磷酸化,导致刺激肌动蛋白聚合,从而进一步增加力,即力增强,并且可能是锁存。